Ireland’s crucial pharmaceutical sector appears to have largely avoided a new US tariff rate for now, amid a broader 20% tax imposed on other goods from the European Union.
There is ‘no justification’ for US tariffs on the EU which will impact Ireland, Irish premier Micheal Martin has said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback